FRANK KARBE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FRANK KARBE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FRANK KARBE. FRANK KARBE is a Director in ADURO BIOTECH, INC. ($ADRO) and a Director in Arbutus Biopharma Corp ($TKMR) and a Principal Fin'l & Accounting in Myovant Sciences Ltd. ($MYOV).
Address: C/O EXELIXIS, INC 170 HARBOR WAY SOUTH SAN FRANCISCO 94080 CA
Companies in which FRANK KARBE is an Insider
Arbutus Biopharma Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FRANK KARBE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 23 2017
$TKMR Market Capitalization: $138.47M
$TKMR Previous Close: $2.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CHINOOK THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FRANK KARBE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 28 2020
$ADRO Market Capitalization: $745.72M
$ADRO Previous Close: $11.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Myovant Sciences Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FRANK KARBE: Principal Fin'l & Accounting
Holdings: 215,528 shares
Current Value: $2,299,684
Latest Transaction: Apr 19 2021
$MYOV Market Capitalization: $630.81M
$MYOV Previous Close: $10.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of FRANK KARBE
Sentiment: All, TKMR, ADRO, MYOV
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | A | 17.88 | 97,534 | 1,743,908 | 97,534 | |
| Apr 19 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Grant | A | 0.00 | 63,138 | 0 | 215,528 | 152.4 K to 215.5 K (+41.43 %) |
| Apr 08 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 18.63 | 11,080 | 206,420 | 152,390 | 163.5 K to 152.4 K (-6.78 %) |
| Feb 18 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 750 | 3,833 | 181,744 | |
| Feb 18 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 750 | 3,833 | 181,744 | |
| Feb 18 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 21.40 | 750 | 16,050 | 163,470 | 164.2 K to 163.5 K (-0.46 %) |
| Feb 18 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 21.40 | 750 | 16,050 | 163,470 | 164.2 K to 163.5 K (-0.46 %) |